Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
The purpose of the study is to determine the efficacy and safety of two dose levels of micafungin versus caspofungin in the treatment of proven invasive candidiasis or candidemia. The maximum length of antifungal treatment is 4 weeks except in pre-defined patients where maximum length of therapy is 8 weeks. A post treatment assessment will be conducted at 2 weeks and 6 weeks after the last dose of all antifungal treatments.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must have candidemia or invasive candidiasis.
You may not be if
Patients who have received an echinocandin within one month prior to study entry.
Patients who have received more than two days of prior systemic antifungal therapy for the current infection.
Clareo Health | Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
